BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 30530185)

  • 1. CHCHD10 is involved in the development of Parkinson's disease caused by CHCHD2 loss-of-function mutation p.T61I.
    Mao C; Wang H; Luo H; Zhang S; Xu H; Zhang S; Rosenblum J; Wang Z; Zhang Q; Tang M; Shepard MJ; Wang X; Wang Y; Zhuang Z; Shi C; Xu Y
    Neurobiol Aging; 2019 Mar; 75():38-41. PubMed ID: 30530185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CHCHD2 harboring Parkinson's disease-linked T61I mutation precipitates inside mitochondria and induces precipitation of wild-type CHCHD2.
    Cornelissen T; Spinazzi M; Martin S; Imberechts D; Vangheluwe P; Bird M; De Strooper B; Vandenberghe W
    Hum Mol Genet; 2020 May; 29(7):1096-1106. PubMed ID: 32068847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PD-linked CHCHD2 mutations impair CHCHD10 and MICOS complex leading to mitochondria dysfunction.
    Zhou W; Ma D; Sun AX; Tran HD; Ma DL; Singh BK; Zhou J; Zhang J; Wang D; Zhao Y; Yen PM; Goh E; Tan EK
    Hum Mol Genet; 2019 Apr; 28(7):1100-1116. PubMed ID: 30496485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CHCHD2 Thr61Ile mutation impairs F1F0-ATPase assembly in
    Chen X; Lin Y; Zhang Z; Tang Y; Ye P; Dai W; Zhang W; Liu H; Peng G; Huang S; Qiu J; Guo W; Zhu X; Wu Z; Kuang Y; Xu P; Zhou M
    Neural Regen Res; 2024 Jan; 19(1):196-204. PubMed ID: 37488867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CHCHD2 p.Thr61Ile knock-in mice exhibit motor defects and neuropathological features of Parkinson's disease.
    Fan L; Zhang S; Li X; Hu Z; Yang J; Zhang S; Zheng H; Su Y; Luo H; Liu X; Fan Y; Sun H; Zhang Z; Miao J; Song B; Xia Z; Shi C; Mao C; Xu Y
    Brain Pathol; 2023 May; 33(3):e13124. PubMed ID: 36322611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathological characterization of a novel mouse model expressing the PD-linked CHCHD2-T61I mutation.
    Kee TR; Wehinger JL; Gonzalez PE; Nguyen E; McGill Percy KC; Khan SA; Chaput D; Wang X; Liu T; Kang DE; Woo JA
    Hum Mol Genet; 2022 Nov; 31(23):3987-4005. PubMed ID: 35786718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of casein kinase 1 epsilon/delta (Csnk1e/d) in the pathogenesis of familial Parkinson's disease caused by CHCHD2.
    Torii S; Arakawa S; Sato S; Ishikawa KI; Taniguchi D; Sakurai HT; Honda S; Hiraoka Y; Ono M; Akamatsu W; Hattori N; Shimizu S
    EMBO Mol Med; 2023 Sep; 15(9):e17451. PubMed ID: 37578019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CHCHD2 and CHCHD10-related neurodegeneration: molecular pathogenesis and the path to precision therapy.
    Shammas MK; Huang TH; Narendra DP
    Biochem Soc Trans; 2023 Apr; 51(2):797-809. PubMed ID: 37021679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of CHCHD10-CHCHD2 complexes required for respiration underlies the pathogenicity of a CHCHD10 mutation in ALS.
    Straub IR; Janer A; Weraarpachai W; Zinman L; Robertson J; Rogaeva E; Shoubridge EA
    Hum Mol Genet; 2018 Jan; 27(1):178-189. PubMed ID: 29121267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Twin CHCH Proteins, CHCHD2, and CHCHD10: Key Molecules of Parkinson's Disease, Amyotrophic Lateral Sclerosis, and Frontotemporal Dementia.
    Imai Y; Meng H; Shiba-Fukushima K; Hattori N
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30791515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic analysis of CHCHD2 and CHCHD10 in Italian patients with Parkinson's disease.
    Rubino E; Brusa L; Zhang M; Boschi S; Govone F; Vacca A; Gai A; Pinessi L; Lopiano L; Rogaeva E; Rainero I
    Neurobiol Aging; 2017 May; 53():193.e7-193.e8. PubMed ID: 28108040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of CHCHD2 mutations in Parkinson's disease in a Taiwanese population.
    Fan TS; Lin HI; Lin CH; Wu RM
    Neurobiol Aging; 2016 Feb; 38():218.e1-218.e2. PubMed ID: 26725463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation analysis of CHCHD2 gene in Chinese Han familial essential tremor patients and familial Parkinson's disease patients.
    Gao C; Chen YM; Sun Q; He YC; Huang P; Wang T; Li DH; Liang L; Liu J; Xiao Q; Chen SD
    Neurobiol Aging; 2017 Jan; 49():218.e9-218.e11. PubMed ID: 27814991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation analysis of CHCHD2 gene in Chinese familial Parkinson's disease.
    Liu Z; Guo J; Li K; Qin L; Kang J; Shu L; Zhang Y; Wei Y; Yang N; Luo Y; Sun Q; Xu Q; Yan X; Tang B
    Neurobiol Aging; 2015 Nov; 36(11):3117.e7-3117.e8. PubMed ID: 26343503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo studies of the ALS-FTLD protein CHCHD10 reveal novel mitochondrial topology and protein interactions.
    Burstein SR; Valsecchi F; Kawamata H; Bourens M; Zeng R; Zuberi A; Milner TA; Cloonan SM; Lutz C; Barrientos A; Manfredi G
    Hum Mol Genet; 2018 Jan; 27(1):160-177. PubMed ID: 29112723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in CHCHD2 cause α-synuclein aggregation.
    Ikeda A; Nishioka K; Meng H; Takanashi M; Hasegawa I; Inoshita T; Shiba-Fukushima K; Li Y; Yoshino H; Mori A; Okuzumi A; Yamaguchi A; Nonaka R; Izawa N; Ishikawa KI; Saiki H; Morita M; Hasegawa M; Hasegawa K; Elahi M; Funayama M; Okano H; Akamatsu W; Imai Y; Hattori N
    Hum Mol Genet; 2019 Dec; 28(23):3895-3911. PubMed ID: 31600778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic analysis of CHCHD2 gene in Chinese Parkinson's disease.
    Li NN; Wang L; Tan EK; Cheng L; Sun XY; Lu ZJ; Li JY; Zhang JH; Peng R
    Am J Med Genet B Neuropsychiatr Genet; 2016 Dec; 171(8):1148-1152. PubMed ID: 27626775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CHCHD2 accumulates in distressed mitochondria and facilitates oligomerization of CHCHD10.
    Huang X; Wu BP; Nguyen D; Liu YT; Marani M; Hench J; Bénit P; Kozjak-Pavlovic V; Rustin P; Frank S; Narendra DP
    Hum Mol Genet; 2018 Nov; 27(22):3881-3900. PubMed ID: 30084972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation analysis of CHCHD2 and CHCHD10 in Italian patients with mitochondrial myopathy.
    Rubino E; Zhang M; Mongini T; Boschi S; Vercelli L; Vacca A; Govone F; Gai A; Giordana MT; Grinberg M; Rogaeva E; Rainero I
    Neurobiol Aging; 2018 Jun; 66():181.e1-181.e2. PubMed ID: 29519717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial CHCHD2 and CHCHD10: Roles in Neurological Diseases and Therapeutic Implications.
    Zhou W; Ma D; Tan EK
    Neuroscientist; 2020 Apr; 26(2):170-184. PubMed ID: 31526091
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.